These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 30384323)

  • 1. An improved model of ethanol and nicotine co-use in female P rats: Effects of naltrexone, varenicline, and the selective nicotinic α6β2* antagonist r-bPiDI.
    Maggio SE; Saunders MA; Nixon K; Prendergast MA; Zheng G; Crooks PA; Dwoskin LP; Bell RL; Bardo MT
    Drug Alcohol Depend; 2018 Dec; 193():154-161. PubMed ID: 30384323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the nicotinic agonist varenicline, nicotinic antagonist r-bPiDI, and DAT inhibitor (R)-modafinil on co-use of ethanol and nicotine in female P rats.
    Maggio SE; Saunders MA; Baxter TA; Nixon K; Prendergast MA; Zheng G; Crooks P; Dwoskin LP; Slack RD; Newman AH; Bell RL; Bardo MT
    Psychopharmacology (Berl); 2018 May; 235(5):1439-1453. PubMed ID: 29455292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of ethanol, naltrexone, nicotine and varenicline in an ethanol and nicotine co-use model in Sprague-Dawley rats.
    Chandler CM; Maggio SE; Peng H; Nixon K; Bardo MT
    Drug Alcohol Depend; 2020 Jul; 212():107988. PubMed ID: 32387915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic challenges for concurrent ethanol and nicotine consumption: naltrexone and varenicline fail to alter simultaneous ethanol and nicotine intake by female alcohol-preferring (P) rats.
    Waeiss RA; Knight CP; Hauser SR; Pratt LA; McBride WJ; Rodd ZA
    Psychopharmacology (Berl); 2019 Jun; 236(6):1887-1900. PubMed ID: 30758525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. bPiDI: a novel selective α6β2* nicotinic receptor antagonist and preclinical candidate treatment for nicotine abuse.
    Wooters TE; Smith AM; Pivavarchyk M; Siripurapu KB; McIntosh JM; Zhang Z; Crooks PA; Bardo MT; Dwoskin LP
    Br J Pharmacol; 2011 May; 163(2):346-57. PubMed ID: 21232049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Nicotinic α6-Subunit Selective Antagonist bPiDI Reduces Alcohol Self-Administration in Alcohol-Preferring Rats.
    Srisontiyakul J; Kastman HE; Krstew EV; Govitrapong P; Lawrence AJ
    Neurochem Res; 2016 Dec; 41(12):3206-3214. PubMed ID: 27573375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of Combining Varenicline and Naltrexone for Smoking Cessation and Drinking Reduction: A Randomized Clinical Trial.
    Ray LA; Green R; Enders C; Leventhal AM; Grodin EN; Li G; Lim A; Hartwell E; Venegas A; Meredith L; Nieto SJ; Shoptaw S; Ho D; Miotto K
    Am J Psychiatry; 2021 Sep; 178(9):818-828. PubMed ID: 34080890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. r-bPiDI, an α6β2* Nicotinic Receptor Antagonist, Decreases Nicotine-Evoked Dopamine Release and Nicotine Reinforcement.
    Beckmann JS; Meyer AC; Pivavarchyk M; Horton DB; Zheng G; Smith AM; Wooters TE; McIntosh JM; Crooks PA; Bardo MT; Dwoskin LP
    Neurochem Res; 2015 Oct; 40(10):2121-30. PubMed ID: 26227997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Varenicline decreases nicotine but not alcohol self-administration in genetically selected Marchigian Sardinian alcohol-preferring (msP) rats.
    Scuppa G; Cippitelli A; Toll L; Ciccocioppo R; Ubaldi M
    Drug Alcohol Depend; 2015 Nov; 156():126-132. PubMed ID: 26383997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of varenicline on ethanol- and food-maintained responding in a concurrent access procedure.
    Ginsburg BC; Lamb RJ
    Alcohol Clin Exp Res; 2013 Jul; 37(7):1228-33. PubMed ID: 23413834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of varenicline on operant self-administration of alcohol and/or nicotine in a rat model of co-abuse.
    Funk D; Lo S; Coen K; Lê AD
    Behav Brain Res; 2016 Jan; 296():157-162. PubMed ID: 26365457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effects of Long-Term Varenicline Administration on Ethanol and Sucrose Seeking and Self-Administration in Male P Rats.
    Czachowski CL; Froehlich JC; DeLory M
    Alcohol Clin Exp Res; 2018 Feb; 42(2):453-460. PubMed ID: 29168193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bupropion, Alone and in Combination with Naltrexone, Blunts Binge-Like Ethanol Drinking and Intake Following Chronic Intermittent Access to Ethanol in Male C57BL/6J Mice.
    Navarro M; Luhn KL; Kampov-Polevoy AB; Garbutt JC; Thiele TE
    Alcohol Clin Exp Res; 2019 May; 43(5):783-790. PubMed ID: 30817015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of α4- and α6-containing nicotinic receptors in the acquisition and maintenance of nicotine self-administration.
    Madsen HB; Koghar HS; Pooters T; Massalas JS; Drago J; Lawrence AJ
    Addict Biol; 2015 May; 20(3):500-12. PubMed ID: 24750355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combining Varenicline (Chantix) with Naltrexone Decreases Alcohol Drinking More Effectively Than Does Either Drug Alone in a Rodent Model of Alcoholism.
    Froehlich JC; Fischer SM; Dilley JE; Nicholson ER; Smith TN; Filosa NJ; Rademacher LC
    Alcohol Clin Exp Res; 2016 Sep; 40(9):1961-70. PubMed ID: 27469281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The contribution of agonist and antagonist activities of α4β2* nAChR ligands to smoking cessation efficacy: a quantitative analysis of literature data.
    Rollema H; Hurst RS
    Psychopharmacology (Berl); 2018 Sep; 235(9):2479-2505. PubMed ID: 29980822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring Sex Differences in the Attenuation of Ethanol Drinking by Naltrexone in Dependent Rats During Early and Protracted Abstinence.
    Matzeu A; Terenius L; Martin-Fardon R
    Alcohol Clin Exp Res; 2018 Dec; 42(12):2466-2478. PubMed ID: 30320880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of 5-HT2A receptor agonist 2,5-dimethoxy-4-iodoamphetamine on alcohol consumption in Long-Evans rats.
    Berquist MD; Fantegrossi WE
    Behav Pharmacol; 2021 Aug; 32(5):382-391. PubMed ID: 33595958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of an oral operant nicotine/ethanol co-use model in alcohol-preferring (p) rats.
    Hauser SR; Katner SN; Deehan GA; Ding ZM; Toalston JE; Scott BJ; Bell RL; McBride WJ; Rodd ZA
    Alcohol Clin Exp Res; 2012 Nov; 36(11):1963-72. PubMed ID: 22486609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological characterization of the 20% alcohol intermittent access model in Sardinian alcohol-preferring rats: a model of binge-like drinking.
    Sabino V; Kwak J; Rice KC; Cottone P
    Alcohol Clin Exp Res; 2013 Apr; 37(4):635-43. PubMed ID: 23126554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.